CSL Ltd (CSL) discovers, develops, manufactures, commercializes and distributes biopharmaceuticals and related products. Its portfolio encompasses plasma-derived products for the treatment of hemophilia, hereditary angioedema, von Willebrand disease, inherited primary and secondary immune deficiencies, respiratory disease, neurological disorders and protein-based medicines for treating serious human illnesses. The company also provides products for the prevention of hemolytic disease in newborns, infection in solid organ transplant recipients and to treat specific infections for victims of trauma and burns. CSL markets an array of vaccines, anti-venoms and pharmaceutical products of various other manufacturers. The company sells its products in Australia, Germany, Switzerland, the US, the UK and other countries. CSL is headquartered in Parkville, Victoria, Australia.

Headquarters Australia

Address 45 Poplar Road, Parkville, Melbourne, Victoria, 3052


Telephone 61 3 93891911

No of Employees 30,000

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange CSL (ASX)

Revenue (2022) $10.6B 12.7% (2022 vs 2021)

EPS XXX

Net Income (2022) XXX 13% (2022 vs 2021)

Market Cap* $98.2B

Net Profit Margin (2021) XXX 0.3% (2022 vs 2021)

* As of and is in US$

Access premium data and analytics for CSL Ltd

380+

Clinical Trials

Determine CSL Ltd go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

180+

Catalyst Calendar

Proactively evaluate CSL Ltd’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

130+

Marketed Drugs

Understand CSL Ltd’s commercialized product portfolio to stay one step ahead of the market.

120+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for CSL Ltd’s relevant decision makers and contact details.

90+

Pipeline Drugs

Identify which of CSL Ltd’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

30+

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

20+

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

6

Sales & Consensus Forecasts

Understand the current and future drug revenue for CSL Ltd and assess market opportunity for new entrants with patient population 8-year forecasts.

1

Investigators

Review investigator profiles and find information on trial contacts across CSL Ltd, including performance indicators like number of completed trials, and linked attributes such as rehiring statistics.

250+

Install Base

Install Base provides a holistic and a granular view of the IT product/service deployments from leading vendors. Explore IT infrastructure categories, solution and product/service areas deployed by a prospect.

1

IT Services Contracts

Improve competitive bidding with insights into all publicly disclosed IT services contracts for CSL Ltd (including IT outsourcing, business process outsourcing, systems integration & consulting and more).

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on CSL Ltd’s likely spend across technology areas enabling you to understand the digital strategy.

Subscribe to Company Analytics & gain access to premium industry data & analytics Subscribe to Company Analytics & gain access to premium industry data & analytics Start Here

Products and Services

Products
Plasma-derived Therapies
Vaccines
Diagnostics Products
XXX
XXX
XXX
Subscribe to Company Analytics for access to more products & services data Subscribe to Company Analytics for access to more products & services data Learn More

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2022 Regulatory Approval In November, the company announced that the U.S. Food and Drug Administration (FDA) approved its HEMGENIX.
2022 Contracts/Agreements In November, CSL Seqirus entered into a collaboration and license agreement with Arcturus Therapeutics Holdings Inc to access their late stage self-amplifying mRNA (sa-mRNA) vaccine platform technology.
2022 Corporate Changes/Expansions In September, CSL Behring opened a new facility in Marburg, Germany.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Get Started
Image for loader

Competitor Comparison

Key Parameters CSL Ltd AbbVie Inc GSK plc Bristol-Myers Squibb Co AstraZeneca Plc
Headquarters Australia United States of America United Kingdom United States of America United Kingdom
City Melbourne North Chicago Brentford New York Cambridge
State/Province Victoria Illinois - New York Cambridgeshire
No. of Employees 30,000 50,000 90,096 32,200 83,100
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Brian McNamee Chairman Executive Board 2018 64
Paul Perreault Managing Director; Chief Executive Officer; Director Executive Board 2013 64
Joy Linton Chief Financial Officer Senior Management 2020 55
Paul McKenzie Chief Operating Officer Senior Management 2019 55
Bill Mezzanotte, M.D. Executive Vice President; Chief Medical Officer; Head - Research & Development Senior Management 2020 62
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Gain more insight into company management & employee structure with Company Analytics Gain more insight into company management & employee structure with Company Analytics Subscribe
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company Analytics

Contact the team or request a demo to find out how our data can drive your business forward

Why are you leaving?